Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SMARCD1/SMARCD3 Polyclonal Antibody
SMARCD1/SMARCD3 Polyclonal Antibody
Supplier: Thermo Scientific PA567704
Description
SMARCD1/SMARCD3 Polyclonal Antibody for Western Blot

Specifications
SMARCD1/SMARCD3 | |
Polyclonal | |
Unconjugated | |
Smarcd3 | |
1500001J14Rik; 2210409C08Rik; 60 kDa BRG-1/Brm-associated factor subunit A; 60 kDa BRG-1/Brm-associated factor subunit C; AA407987; Baf60a; Baf60c; BRG1-associated factor 60A; BRG1-associated factor 60C; chromatin remodeling complex BAF60A subunit; chromatin remodeling complex BAF60C subunit; CRACD1; CRACD3; D15Kz1; mammalian chromatin remodeling complex BRG1-associated factor 60A; mammalian chromatin remodeling complex BRG1-associated factor 60C; mBAF60c; Protein D15KZ1; Rsc6p; Smarcd1; SMARCD3; SWI/SNF complex 60 kDa subunit; SWI/SNF complex 60 kDa subunit A; SWI/SNF complex 60 kDa subunit C; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3, isoform 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3; Swp73-like protein | |
Rabbit | |
Affinity Chromatography | |
RUO | |
6602, 6604, 66993, 83797 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q61466, Q6P9Z1, Q6STE5, Q96GM5 | |
SMARCD1, Smarcd3 | |
Synthesized peptide derived from human SMARCD1/SMARCD3. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction